ArticleJournal of chemotherapy (Florence, Italy)2012

Phase I trial of bortezomib during maintenance phase after high dose melphalan and autologous stem cell transplantation in patients with multiple myeloma.

Muneer H Abidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.